Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuterol-HFA-MDI Safety and Efficacy in Pediatric Asthma
NCT00577655Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Aug 2007
- Primary completion
- Jul 2008
- Countries
- 1
01
Overview
A Phase 3 trial of albuterol dry powder inhaler in asthma, sponsored by Teva Pharmaceutical Industries Ltd.. Started Aug 2007; status: completed.
02
Drugs
albuterol dry powder inhaler
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00577655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00577655.